Search details
1.
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases.
Int J Mol Sci
; 24(2)2023 Jan 12.
Article
in English
| MEDLINE | ID: mdl-36674998
2.
Antioxidants Prevent Iron Accumulation and Lipid Peroxidation, but Do Not Correct Autophagy Dysfunction or Mitochondrial Bioenergetics in Cellular Models of BPAN.
Int J Mol Sci
; 24(19)2023 Sep 26.
Article
in English
| MEDLINE | ID: mdl-37834028
3.
Neurodegeneration, Mitochondria, and Antibiotics.
Metabolites
; 13(3)2023 Mar 12.
Article
in English
| MEDLINE | ID: mdl-36984858
4.
Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.
Orphanet J Rare Dis
; 18(1): 80, 2023 04 12.
Article
in English
| MEDLINE | ID: mdl-37046296
5.
Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration.
Pharmaceuticals (Basel)
; 16(10)2023 Sep 26.
Article
in English
| MEDLINE | ID: mdl-37895830
6.
Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases.
Biomolecules
; 13(12)2023 12 13.
Article
in English
| MEDLINE | ID: mdl-38136659
7.
Actin Polymerization Defects Induce Mitochondrial Dysfunction in Cellular Models of Nemaline Myopathies.
Antioxidants (Basel)
; 12(12)2023 Nov 21.
Article
in English
| MEDLINE | ID: mdl-38136143
8.
Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases.
Front Pharmacol
; 13: 862085, 2022.
Article
in English
| MEDLINE | ID: mdl-35370630
Results
1 -
8
de 8
1
Next >
>>